Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A(2A) adenosine receptors

Neuroscience

Volumn 97, Issue 1, 2000, Pages 195-204

  Chen, J F ^a,b   Beilstein, M ^a   Xu, Y H ^a   Turner, T J ^b   Moratalla, R ^a   Standaert, D G ^a   Aloyo, V J ^c   Fink, J S ^a   Schwarzschild, M A ^a  

^a Molec Neurbio Lab Neurol Res L   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

A(2A) Adenosine receptor; Amphetamine; Cocaine; Dopamine receptor; Quinpirole; SKF81297

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENOSINE A2A RECEPTOR; AMPHETAMINE; COCAINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; PSYCHOSTIMULANT AGENT; QUINPIROLE; RACLOPRIDE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DOSE TIME EFFECT RELATION; DRUG MECHANISM; GENE DELETION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KNOCKOUT MOUSE; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEREOTYPY;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; GENOTYPE; LOCOMOTION; MICE; MICE, KNOCKOUT; NEOSTRIATUM; PHENOTYPE; RECEPTOR, ADENOSINE A2A; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, PURINERGIC P1;

EID: 0034037134     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00604-1     Document Type: Article

References (72)

1. Bardo M.T. Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Crit. Rev. Neurobiol. 12:1998;37-67.
2. Barraco R. A. (1991) Behavioral actions of adenosine and related substances. In Adenosine and Adenine Nucleotides as Regulators of Cellular Function. (ed. Phillis J. W.), pp. 339-366. CRC, Boca Raton, FL.
3. Boegman R.J., Vincent S.R. Involvement of adenosine and glutamine receptors in the induction of c-fos in the striatum by haloperidol. Synapse. 22:1996;70-77.
4. 2 receptor regulates apomorphine-induced turning in rats with unilateral dopamine denervation. Psychopharmacology. 103:1991;78-82.
5. Casas M., Ferre S., Cobos A., Grau J.M., Jane F. Relationship between rotational behavior induced by apomorphine and caffeine in rats with unilateral lesion of the nigrostriatal pathway. Neuropharmacology. 28:1989;407-409.
6. 2 receptors. Brain Res. 761:1997;151-155.
7. 2 dopamine receptor mRNA and the proenkephalin mRNA and increases the mu opioid receptors in mouse striatum. Neuroscience. 54:1993;669-680.
8. 2 dopamine receptor mRNA in brain of normal mice and mice lesioned with 6-hydroxydopamine. Neuropharmacology. 30:1991;927-941.
9. 2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19:1999;9192-9200.
10. Chen J., Kelz M.B., Zeng G., Sakai N., Steffen C., Shockett P.E., Picciotto M.R., Duman R.S., Nestler E.J. Transgenic animals with inducible, targeted gene expression in brain. Molec. Pharmac. 54:1998;495-503.
11. Crawley J.N., Belknap J.K., Collins A., Crabbe J.C., Frankel W., Henderson N., Hitzemann R.J., Maxson S.C., Miner L.L., Silva A.J., Wehner J.M., Wynshaw-Boris A., Paylor R. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology. 132:1997;107-124.
12. 3H]-acetylcholine release from different areas of the rat hippocampus. J. Neurochem. 63:1994;207-214.
13. Ferre S. Adenosine-dopamine interactions in the ventral striatum: implications for the treatment of schizophrenia. Psychopharmacology. 133:1997;107-120.
14. Ferre S., Fredholm B.B., Morelli M., Popoli P., Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 10:1997;482-487.
15. Ferre S., Fuxe K., VonEuler G., Johansson G., Fredholm B. Adenosine-dopamine interactions in the brain. Neuroscience. 51:1992;501-512.
16. 2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum. Neuropharmacology. 38:1999;129-140.
17. 2 receptors in rat striatal membranes. Proc. natn. Acad. Sci. U.S.A. 88:1991;7238-7241.
18. 2 dopamine receptors in rat striatum. Molec. Brain Res. 14:1992;186-195.
19. Gingrich J.R., Roder J. Inducible gene expression in the nervous system of transgenic mice. A. Rev. Neurosci. 21:1998;377-405.
20. Green R.D., Proudfit H.K., Yeung S.-M.H. Modulation of striatal dopaminergic function by local injection of 5′-N-Ethylcarboxamide adenosine. Science. 281:1982;58-61.
21. Grondin R., Bedard P.J., Tahar A.H., Gregoire L., Mori A., Kase H. Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys. Neurology. 52:1999;1673-1677.
22. Heffner T.G., Wiley J.N., Williams A.E., Bruns R.F., Coughenour L.L., Downs D.A. Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice. Psychopharmacology. 91:1989;31-37.
23. Howell L.L., Coffin V.L., Spealman R.D. Behavioral and physiological effects of xanthines in nonhuman primates. Psychopharmacology. 129:1997;1-14.
24. Hyman S.E. Addiction to cocaine and amphetamine. Neuron. 16:1996;901-904.
25. Jacobson K.A., van Galen P.J.M., Williams M. Adenosine receptors - pharmacology, structure activity relationships, and therapeutic potential. J. med. Chem. 35:1992;407-422.
26. Jacobson K.A., von Lubitz D.K.J.E., Daly J.W., Fredholm B.B. Adenosine receptor ligands: differences with acute versus chronic treatment. Trends pharmac. Sci. 17:1996;108-113.
27. Jiang H., Jackson-Lewis V., Muthane U., Dollison A., Ferreira M., Espinosa A., Parsons B., Przedborski S. Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats. Brain Res. 613:1993;347-351.
28. 2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices. J. Pharmac. exp. Ther. 267:1993;801-808.
29. 2 receptor interactions in animal models of schizophrenia. Eur. J. Pharmac. 295:1996;147-154.
30. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends pharmac. Sci. 13:1992;177-184.
31. 2A receptor-mediated modulation of striatal acetylcholine release in vivo. J. Neurochem. 66:1996;1882-1888.
32. 2A receptor. Nature. 388:1997;674-678.
33. Martinez-Mir M.I., Probst A., Palacios J.M. Adenosine A2 receptors: selective localization in the human basal ganglia and alterations with disease. Neuroscience. 42:1991;697-706.
34. 2 receptor interaction in globus pallidus. Synapse. 22:1996;132-138.
35. Moratalla R., Vallejo M., Elibol B., Graybiel A.M. Network-level changes in inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron. 17:1996;147-156.
36. 2 receptors in unilaterally 6-hydroxydopamine-lesioned rats. Eur. J. Pharmac. 251:1994;21-25.
37. 2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats. Neuroscience. 67:1995;49-55.
38. Nehlig A., Daval J.-L., Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res. Rev. 17:1992;139-170.
39. Nestler E.J. Hard target: understanding dopaminergic neurotransmission. Cell. 79:1994;923-926.
40. Nestler E.J., Aghajanian G.K. Molecular and cellular basis of addiction. Science. 278:1997;58-63.
41. Nikodijevic G., Jacobson K.A., Daly J.W. Locomotor activity in mice during chronic treatment with caffeine and withdrawal. Pharmac. Biochem. Behav. 44:1993;199-216.
42. Okada M., Kiryu K., Kawata Y., Mizuno K., Wada K., Tasaki H., Kaneko S. Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis. Eur. J. Pharmac. 321:1997;181-188.
43. 2 receptors modulate extracellular dopamine levels in rat striatum. Neurosci. Lett. 212:1996;53-56.
44. 2A receptor. Trends pharmac. Sci. 17:1996;364-372.
45. 2A agonist CGS21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex. Neurosci. Lett. 138:1992;169-172.
46. 2A receptors in the induction of C-Fos expression by clozapine and haloperidol. Neuropsychopharmacology. 20:1998;44-51.
47. 2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas. Brain Res. 759:1997;41-49.
48. 2 dopamine agonist cooperatively regulate c-Fos induction in the rat striatum. Neuroscience. 68:1995;721-728.
49. Pollack A.E., Harrison M.B., Wooten G.F., Fink J.S. Differential localization of A2a adenosine receptor mRNA with D1 and D2 dopamine receptor mRNA in striatal output pathways following a selective lesion of striatonigral neurons. Brain Res. 631:1993;161-166.
50. 2A receptor antagonists stimulate motor activity: evidence for an increased effectiveness in aged rats. Neurosci. Lett. 251:1998;201-204.
51. Reynolds G.P. Developments in the drug treatment of schizophrenia. Trends pharmac. Sci. 13:(3):1992;116-121.
52. 2A agonists: a potential new type of atypical antipsychotic. Neuropsychopharmacology. 17:1997;82-91.
53. 2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats. Eur. J. Pharmac. 347:1998;153-158.
54. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 396:1986;157-198.
55. Rocha B.A., Odom L.A., Barron B.A., Ator R., Wild S.A., Forster M.J. Differential responsiveness to cocaine in C57BL/6J and DBA/2J mice. Psychopharmacology. 138:1998;82-88.
56. Rosin D.L., Robeva A., Woodard R.L., Guyenet P.G., Linden J. Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system. J. comp. Neurol. 401:1998;163-186.
57. Schiffmann S.N., Jacobs O., Vanderhaeghen J.-J. Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J. Neurochem. 57:1991;1062-1067.
58. Schiffmann S.N., Vanderhaeghen J-J. Ontogeny of gene expression of adenosine A2 receptor in the striatum: early localization in the patch compartment. J. comp. Neurol. 317:1992;117-128.
59. Sebastiao A.M., Ribeiro J.A. Adenosine A2 receptor-mediated excitatory actions on the nervous system. Prog. Neurobiol. 48:1996;167-189.
60. Segal D. S. and Kuczenski R. (1994) Behavioral pharmaccology of amphetamine. In Amphetamine and its Analogues: Psychopharmacology, Toxicology and Abuse, (eds Cho A. K. and Segal D. S.). Vol. 4, pp. 115-150. Academic, San Diego.
61. Segal D.S., Weinberger S.B., Cahill T., McCunney S.J. Multiple daily amphetamine administrations: behavioral and neurochemical alterations. Science. 207:1980;904-906.
62. Self D.W., Nestler E.J. Molecular mechanisms of drug reinforcement and addiction. A. Rev. Neurosci. 18:1995;463-495.
63. Simpson E.M., Linder C.C., Sargent E.E., Davisson M.T., Mobraaten L.E., Sharp J.J. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nature Genet. 16:1997;19-27.
64. Starr B.S., Starr M.S. Grooming in the mouse is stimulated by the dopamine D1 agonist SKF38393 and by low doses of the D1 antagonist SCH23390, but is inhibited by dopamine D2 agonists, D2 antagonists and high doses of SCH23390. Pharmac. Biochem. Behav. 24:1986;837-839.
65. Steele P.M., Medina J.F., Nores W.L., Mauk M.D. Using genetic mutations to study the neuronal basis of behavior. Cell. 95:1998;879-882.
66. Turgeon S.M., Pollack A.M., Schusheim L., Fink J.S. Effects of selective adenosine A1 and A2a agonists on amphetamine-induced locomotion and c-Fos in striatum and nucleus accumbens. Brain Res. 707:1996;75-80.
67. Turner T.J., Dunlap K. Prolonged time course of glutamate release from nerve terminals: relationship between stimulus duration and the secretory event. J. Neurochem. 64:1995;2022-2033.
68. Weaver D.R. A2A adenosine receptor gene expression in developing rat brain. Molec. Brain Res. 20:1993;313-327.
69. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54:1998;679-720.
70. Woolverton W.L., Johnson K.M. Neurobiology of cocainne abuse. Trends pharmac. Sci. 13:1992;193-200.
71. Zetterstrom T., Fillenz M. Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release. Eur. J. Pharmac. 180:1990;137-143.
72. Zhou L.W., Qin Z.H., Weiss B. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole. Neuropsychopharmacology. 4:1991;47-55.